Beyond [177Lu]Lu-PSMA: a meta-analysis of safety and efficacy of emerging PSMA radioligand therapy agents

Abstract Background This systematic review and meta-analysis evaluates the safety and efficacy of emerging prostate-specific membrane antigen (PSMA) radioligand therapy (RLT) agents used beyond [¹⁷⁷Lu]Lu-PSMA in metastatic castration-resistant prostate cancer (mCRPC). Methods Systematic searches of...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Ahmed Saad Abdlkadir, Dhuha Al-Adhami, Serin Moghrabi, Mike Machaba Sathekge, Michael Kreissl, Enrique Estrada-Lobato, Hongcheng Shi, Akram Al-Ibraheem
Format:	Artigo
Sprog:	Inglês
Udgivet:	BMC 2026-03-01
Serier:	BMC Cancer
Fag:	PSMA RLT Prostate cancer [²²⁵Ac]Ac-PSMA [¹⁶¹Tb]Tb-PSMA [¹³¹I]PSMA Tandem therapy
Online adgang:	https://doi.org/10.1186/s12885-026-15900-y
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!